Strand-biased defect in C/G transversions in hypermutating immunoglobulin genes in Rev1-deficient mice

Journal of Experimental Medicine

Volumn 203, Issue 2, 2006, Pages 319-323

  Jansen, Jacob G ^a   Langerak, Petra ^b   Tsaalbi Shtylik, Anastasia ^a   Van Den Berk, Paul ^b   Jacobs, Heinz ^b   De Wind, Niels ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYCYTIDINE; DEOXYURIDINE; PROTEIN; PROTEIN REV1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; GENE MUTATION; GENETIC CONSERVATION; GENETIC TRANSCRIPTION; GROWTH RETARDATION; IMMUNOGLOBULIN GENE; LYMPHOCYTE PROLIFERATION; MEMORY CELL; MOUSE; MUTAGENESIS; MUTATION RATE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; SOMATIC HYPERMUTATION; SPLEEN LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; DEOXYCYTIDINE; GENES, IMMUNOGLOBULIN; GUANINE; IMMUNOGLOBULIN D; IMMUNOGLOBULIN M; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NUCLEOTIDYLTRANSFERASES; POINT MUTATION; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; URACIL-DNA GLYCOSIDASE;

EID: 33344468484     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20052227     Document Type: Article

References (23)

1. Prakash, S., R.E. Johnson, and L. Prakash. 2005. Eukaryotic translesion synthesis DNA polymerases: specificity of structure and function. Annu. Rev. Biochem. 74:317-353.
2. Masuda, Y., M. Takahashi, S. Fukuda, M. Sumii, and K. Kamiya. 2002. Mechanisms of dCMP transferase reactions catalyzed by mouse Rev1 protein. J. Biol. Chem. 277:3040-3046.
3. Zhang, Y., X. Wu, O. Rechkoblit, N.E. Geacintov, J.S. Taylor, and Z. Wang. 2002. Response of human REV1 to different DNA damage: preferential dCMP insertion opposite the lesion. Nucleic Acids Res. 30:1630-1638.
4. Gibbs, P.E.M., J. McDonald, R. Woodgate, and C.W. Lawrence. 2005. The relative roles in vivo of Saccharomyces cerevisiae Pol eta, Pol zeta, Rev1 protein and Pol32 in the bypass and mutation induction of an abasic site, T-T (6-4) photoadduct and T-T cis-syn cyclobutane dimer. Genetics. 169:575-582.
5. Simpson, L.J., and J.E. Sale. 2003. Rev1 is essential for DNA damage tolerance and non-templated immunoglobulin gene mutation in a vertebrate cell line. EMBO J. 22:1654-1664.
6. Jansen, J.G., A. Tsaalbi-Shtylik, P. Langerak, F. Calleja, C.M. Meijers, H. Jacobs, and N. de Wind. 2005. The BRCT domain of mammalian Rev1 is involved in regulating DNA translesion synthesis. Nucleic Acids Res. 33:356-365.
7. Guo, C., P.L. Fischhaber, M.J. Luk-Paszyc, Y. Masuda, J. Zhou, K. Kamiya, C. Kisker, and E.C. Friedberg. 2003. Mouse Rev1 protein interacts with multiple DNA polymerases involved in translesion DNA synthesis. EMBO J. 22:6621-6630.
8. Ohashi, E., Y. Murakumo, N. Kanjo, J. Akagi, C. Masutani, F. Hanaoka, and H. Ohmori. 2004. Interaction of hREV1 with three human Y-family DNA polymerases. Genes Cells. 9:523-531.
9. Tissier, A., P. Kannouche, M.P. Reck, A.R. Lehmann, R.P. Fuchs, and A. Cordonnier. 2004. Co-localization in replication foci and interaction of human Y-family members, DNA polymerase pol eta and REVl protein. DNA Repair (Amst.). 3:1503-1514.
10. Acharya, N., L. Haracska, R.E. Johnson, I. Unk, S. Prakash, and L. Prakash. 2005. Complex formation of yeast rev1 and rev7 proteins: a novel role for the polymerase-associated domain. Mol. Cell. Biol. 25:9734-9740.
11. Neuberger, M.S., R.S. Harris, J. Di Noia, and S.K. Petersen-Mahrt. 2003. Immunity through DNA deamination. Trends Biochem. Sci. 28:305-312.
12. Rajewsky, K. 1996. Clonal selection and learning in the antibody system. Nature. 381:751-758.
13. Muramatsu, M., K. Kinoshita, S. Fagarasan, S. Yamada, Y. Shinkai, and T. Honjo. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 102:553-563.
14. Diaz, M., and C. Lawrence. 2005. An update on the role of translesion synthesis DNA polymerases in Ig hypermutation. Trends Immunol. 26:215-220.
15. Rada, C., J.M. Di Noia, and M.S. Neuberger. 2004. Mismatch recognition and uracil excision provide complementary paths to both Ig switching and the A/T-focused phase of somatic mutation. Mol. Cell. 16:163-171.
16. Van Sloun, P.P., I. Varlet, E. Sonneveld, J.J. Boei, R.J. Romeijn, J.C. Eeken, and N. de Wind. 2002. Involvement of mouse Rev3 in tolerance of endogenous and exogenous DNA damage. Mol. Cell. Biol. 22:2159-2169.
17. McDonald, J.P., E.G. Frank, B.S. Plosky, I.B. Rogozin, C. Masutani, F. Hanaoka, R. Woodgate, and P.J. Gearhart. 2003. 129-derived strains of mice are deficient in DNA polymerase iota and have normal immunoglobulin hypermutation. J. Exp. Med. 198:635-643.
18. Jacobs, H., Y. Fukita, G.T. van der Horst, J. de Boer, G. Weeda, J. Essers, N. de Wind, B.P. Engelward, L. Samson, S. Verbeek, et al. 1998. Hypermutation of immunoglobulin genes in memory B cells of DNA repair-deficient mice. J. Exp. Med. 187:1735-1743.
19. Ross, A.L., and J.E. Sale. 2005. The catalytic activity of REV1 is employed during immunoglobulin gene diversification in DT40. Mol. Immunol. In press.
20. Rada, C., G.T. Williams, H. Nilsen, D.E. Barnes, T. Lindahl, and M.S. Neuberger. 2002. Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr. Biol. 12:1748-1755.
21. Delbos, F., A. de Smet, A. Faili, S. Aoufouchi, J.C. Weill, and C.A. Reynaud. 2005. Contribution of DNA polymerase eta to immunoglobulin gene hypermutation in the mouse. J. Exp. Med. 201:1191-1196.
22. Martomo, S.A., W.W. Yang, R.P. Wersto, T. Ohkumo, Y. Kondo, M. Yokoi, C. Masutani, F. Hanaoka, and P.J. Gearhart. 2005. Different mutation signatures in DNA polymerase eta- and MSH6-deficient mice suggest separate roles in antibody diversification. Proc. Natl. Acad. Sci. USA. 102:8656-8661.
23. Kabat, E.A., and T.T. Wu. 1971. Attempts to locate complementarity- determining residues in the variable positions of light and heavy chains. Ann. N. Y. Acad. Sci. 190:382-393.